Abstract
The differential diagnosis between benign and malignant pancreatic cystic lesions may be very difficult. We recently found that F-18-.uorodeoxyglucose positron emission tomography (18-FDG PET) was useful for the preoperative work-up of pancreatic cystic lesions. This study was undertaken to confirm these results. From February 2000 to July 2003, 50 patients with a pancreatic cystic lesion were prospectively investigated with 18-FDG PET in addition to helical computed tomography (CT) and, in some instances, magnetic resonance imaging (MRI). The validation of diagnosis was based on pathologic findings after surgery (n = 31), percutaneous biopsy (n = 4), and according to follow-up in 15 patients. The 18-FDG PET was analyzed visually and semiquantitatively using the standard uptake value (SUV). The accuracy of FDG PET and CT was determined for preoperative diagnosis of malignant cystic lesions. Seventeen patients had malignant cystic lesions. Sixteen (94%) showed increased 18-FDG uptake (SUV >2.5), including two patients with carcinoma in situ. Eleven patients (65%) were correctly identified as having malignancy by CT. Thirty-three patients had benign tumors: two patients showed increased 18-FDG uptake, and four patients showed CT findings of malignancy. Sensitivity, specificity, positive and negative predictive value, and accuracy of 18-FDG PET and CT in detecting malignant tumors were 94%, 94%, 89%, 97%, and 94% and 65%, 88%, 73%, 83%, and 80%, respectively. 18-FDG PET is accurate in identifying malignant pancreatic cystic lesions and should be used in combination with CT in the preoperative evaluation of patients with pancreatic cystic lesions. A negative result with 18-FDG PET may avoid unnecessary operation in asymptomatic or high-risk patients.
Similar content being viewed by others
References
Kloppel G, Solcia E, Longnecker DS, et al. Histological Typing of Tumours of the Exocrine Pancreas (World Health Organization), 2nd ed. Berlin, Springer, 1996.
Fernandez del Castillo C, Targarona J, Thayer SP, Rattner DW, Brugge WR, Warshaw AL. Incidental pancreatic cysts. Clinicopathologic characteristics and comparison with symptomatic patients. Arch Surg 2003;138:427–434.
Demos TC, Posniak HV, Harmath C, Olson MC, Aranha G. Cystic lesions of the pancreas. AJR Am J Roentgenol 2002; 179:1375–1388.
Kalra MK, Maher MM, Sahani DV, Digmurthy S, Saini S. Current status of imaging in pancreatic diseases. J Comput Assist Tomogr 2002;26:661–675.
Kalra MK, Maher MM, Boland GW, Saini S, Fischman AJ. Correlation of positron emission tomography and CT in evaluating pancreatic tumors: Technical and clinical implications. AJR Am J Roentgenol 2003;181:387–393.
Lewandrowski KB, Lee J, Southern JF, et al. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: A new approach to the preoperative assessment of pancreatic cystic lesions. AJR Am J Roentgenol 1995;164:815–819.
Sperti C, Pasquali C, Guolo P, et al. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.Cancer 1996;78:237–243.
Van Dam J. EUS in cystic lesions of the pancreas. Gastrointest Endosc 2002;56(Suppl 4):S91-S93.
Hernandez LV, Mishra G, Forsmark C, et al. Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas. Pancreas 2002;25:222–228.
Sand JA, Hyoty MK, Mattila J, Dagorn JC, Nordback JH. Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions of the pancreas. Surgery 1996;119:275–280.
Ahmad NA, Kochman ML, Lewis JD, Ginsberg GG. Can EUS alone differentiate between malignant and benign cystic lesions of the pancreas? Am J Gastroenterol 2001;96:3295–3300.
Van Heertum RL, Fawwaz RA. The role of nuclear medicine in the evaluation of pancreatic disease. Surg Clin North Am 2001;81:345–358.
Pham KH, Ramaswamy MR, Hawkins RA. Advances in positron emission tomography imaging for the GI tract. Gastrointest Endosc 2002;55(Suppl 7):S53-S63.
Sperti C, Pasquali C, Chierichetti F, Liessi G, Ferlin G, Pedrazzoli S. Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas. Ann Surg 2001;234:675–680.
Yamao K, Ohashi K, Nakamura T, et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary mucinous tumor (IPMT) of the pancreas. Hepatogastroenterology 2001;48:962–966.
Sheehan MK, Beck K, Pckleman J, Aranha GV. Spectrum of cystic neoplasms of the pancreas and their surgical management. Arch Surg 2003;138:657–662.
Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas: Neoplastic disorders of emerging importance. Current state of the art and unanswered questions. J GASTROINTEST SURG 2003;7:417–428.
Bassi C, Salvia R, Molinari E, Biasiutti C, Falconi M, Pederzoli P. Management of 100 consecutive cases of pancreatic serous cystadenoma: Wait for symptoms and see at imaging or vice versa? World J Surg 2003;27:319–323.
Sahani D, Prasad S, Saini S, Mueller P. Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography. Gastrointest Endosc Clin North Am 2002;12:657–672.
Mertz HR, Sechopoulos P, Delbeke D, Leach SD. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc 2000;52:367–371.
Del Frate C, Zanardi R, Mortele K, et al. Advances in imaging for pancreatic disease. Curr Gastroenterol Rep 2002;4:140–148.
Bounds BC, Brugge WR. EUS diagnosis of cystic lesions of the pancreas. Int J Gastrointest Cancer 2001;30:27–31.
Song MH, Lee SK, Kim MH, et al. EUS in the evaluation of pancreatic cystic lesions. Gastrointest Endosc 2003;57: 891–896.
Ahmad N, Kochman ML, Brensinger C, et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus non-neoplastic pancreatic cystic lesions. Gastrointest Endosc 2003;58:59–64.
Walsh RM, Henderson JM, Vogt D, et al. Prospective preoperative determination of mucinous pancreatic cystic neoplasms. Surgery 2002;132:628–634.
Frossard JL, Amouyal P, Amouyal G, et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003;98:1516–1524.
Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med 1999;40:1706–1715.
Yoshioka M, Sato T, Furuya T, et al. Positron emission tomography with 2-doxy-2-.uor d-glucose for diagnosis of intraductal papillary mucinous tumors of the pancreas with parenchymal invasion. J Gastroenterol 2002;38:1189–1193.
McHenry L Jr, Fletcher JW, Tann M, et al. Cystic tumors of the pancreas: Evaluation with 18-fluorodeoxyglucose positron emission tomography (PET) and endoscopic ultrasoundguided fine needle aspiration (EUS-FNA). Presented at the Annual Meeting of Digestive Disease Week, Orlando, Florida, May 17–22, 2003, W1204 (abstract).
Wiesenauer CA, Schmidt M, Cummings OW, et al. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 2003;138:610–618.
Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin North Am 2001;39:893–917.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-.uorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972–1980.
Hany TF, Steinert HC, Gerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with inline PET-CT system: Initial results. Radiology 2002;225: 575–581.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Ministero Università e Ricerca Scientifica (Cofin 2001068593-001), Rome, Italy.
Rights and permissions
About this article
Cite this article
Sperti, C., Pasquali, C., Decet, G. et al. F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: A prospective study. J Gastrointest Surg 9, 22–29 (2005). https://doi.org/10.1016/j.gassur.2004.10.002
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2004.10.002